Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Ametropia: early-phase trial registry
2 of 6 indexed Ametropia trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #2,866 of 28,707 conditions by registered trial count.
6 US clinical trials · 2 currently recruiting · #2,866 of 28,707 conditions by registered trial count
Ametropia: 6 US clinical trials tracked, 2 recruiting.
Ametropia is the subject of 6 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Lentechs, running 1 of these trials.
Enrollment posture brief
Registry condition ametropia
OPEN 2 | RECR 33% | LATE 0 | EARLY 1 | RANK #2866 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Adherence, Treatment (33% recruiting · 6 trials)
Ametropia lists 2 open slots (33% of 6 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Ametropia on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Ametropia is recruiting below its size-band peers.
2 of 6 indexed trials (33.3%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Ametropia research.
Lentechs accounts for 1 of 6 trials (16.7%). 6 distinct sponsors appear on at least one study for this condition label.
-
Typical Ametropia enrolment sits around 120 participants.
Median target enrolment is 120 among the 6 trials that report a genuine target (sentinel values excluded). 2 of those (33.3%) plan for fewer than 100 participants.
-
Ametropia research is mostly interventional.
5 interventional and 1 observational studies make up this index (83.3% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
6 total, page 1 of 1
North American Comfilcon A Clinical Study
CooperVision International Limited (CVIL)
NCT06902584
Post Marketing Clinical Study on the Efficacy of Lenses From a New Prescription Protocol
Essilor International
NCT07168564
Safety and Acceptability of Using a Rewetting Drop With Contact Lens Wear
Allergan
NCT00691197
Clinical Performance of Two Commercial, Daily Disposable Contact Lenses
Alcon Research
NCT05010512
Evaluation of Monthly Replacement Lenses in Habitual Soft Contact Lens Wearers Who Report Frequent Digital Devise Use
CooperVision
NCT05166902
Apioc Contact Lens Feasibility
Lentechs
NCT03688672
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Ametropia records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Ametropia trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Ametropia page
6 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 2 Ametropia trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Lentechs sponsors the most Ametropia trials on record, review their full trial history before evaluating a specific study. See Lentechs's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Ametropia condition card totals 6 registered trials; most-linked intervention Lens B (lehfilcon A lens); top US site state Pennsylvania. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.